Glycostem CEO Troels Jordansen presents on 25th June at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq.
Glycostem is invited to the second largest investor conference: the Jefferies Virtual Healthcare Conference on 4th July. The interest in off-the-shelf NK-cells with no CRS issues is increasing rapidly.
Glycostem presents at ACCESS CHINA Online Partnering Day on 15th May, 2020. ACCESS CHINA Partnering Day is the largest online corporate access event between China and Western Biopharma Industry. Glycostem is looking for investors and partnering opportunities.
On 14th May Glycostem presents virtually a poster at ASGCT 2020 about oNKord® “off-the-shelf” NK therapy closed system manufacturing process and clinical potential in AML, with a perspective on CAR-NK and other NK innovative therapies.
Glycostem participates in Bio CEO on 10th and 11th February 2020 in New York. Glycostem’s CEO Troels Jordansen provides an update on Glycostem.
Glycostem’s CEO Troels Jordansen provides an update on Glycostem at Phacilitate Leaders World & World Stem Cell Summit 2020 between 21st and 24th January 2020 in Miami.